Close

Aquestive Therapeutics (AQST) PT Lowered to $10 at BMO Capital Mar 10, 2022 06:38AM
Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences Jun 9, 2021 08:30AM
Aquestive Therapeutics to Participate in JMP Securities and BMO Capital Market Investor Conferences Jun 9, 2021 08:30AM
Aquestive Therapeutics to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference Jun 16, 2020 08:00AM
Aquestive Therapeutics to Present at BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference Jun 16, 2020 08:00AM


Dec 13, 2019 05:43AM Aquestive Therapeutics Inc. (AQST) Prices 7M Share Common Offering at $5/Sh
Dec 12, 2019 08:00PM Aquestive Therapeutics Announces Pricing of Public Offering of Common Stock
Dec 12, 2019 08:00PM Aquestive Therapeutics Announces Pricing of Public Offering of Common Stock
Dec 10, 2019 04:02PM Aquestive Therapeutics (AQST) Announces Proposed $35M Public Offering of Common Stock
Dec 10, 2019 04:01PM Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
Dec 10, 2019 04:01PM Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
Aug 7, 2019 03:50PM Aquestive Therapeutics (AQST) PT Lowered to $19 at BMO Capital
Mar 15, 2019 06:51AM Aquestive Therapeutics (AQST) PT Lowered to $21 at BMO Capital
Jan 31, 2019 09:43AM Aquestive (AQST) Sublingual Apomorphine Delay 'Not Too Significant' - BMO
Dec 7, 2018 08:00AM Aquestive Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
Nov 26, 2018 04:50AM Aquestive Therapeutics (AQST) PT Lowered to $24 at BMO Capital
Aug 20, 2018 05:15AM BMO Capital Starts Aquestive Therapeutics (AQST) at Outperform
Aug 15, 2018 04:00PM Aquestive Therapeutics Announces Closing of Exercise of Underwriters' Over-Allotment Option in Initial Public Offering
Jul 27, 2018 04:00PM Aquestive Therapeutics Announces Closing of Initial Public Offering
Jul 25, 2018 05:47AM Aquestive Therapeutics, Inc. (AQST) Prices 4.5M Share IPO at $15/Sh
Jul 24, 2018 07:54PM Aquestive Therapeutics Announces Pricing of Initial Public Offering